Literature DB >> 1676992

Human and experimental spongiform encephalopathies: recent progress in pathogenesis.

M C Dal Canto.   

Abstract

The spongiform encephalopathies belong to the group of "slow virus infections" of the nervous system, characterized by a long incubation period, a protracted course and involvement of the nervous system with a lethal outcome. In contrast to the conventional virus infections, such as visna in sheep and progressive multifocal leukoencephalopathy (PML) in humans, the etiological agent for the spongiform encephalopathies has not been clearly defined. The known forms in animals are scrapie in sheep and goats, transmissible mink encephalopathy, and chronic wasting disease of mule deer and elk. In humans, the three known forms are Kuru, now mainly of historical interest, Creutzfeldt-Jakob (CJ) disease and the syndrome of Gerstmann-Straussler-Scheinker (GSS). An important feature of these diseases is the lack of an immune response by the host, which is reflected in the absence of inflammatory infiltrates in the affected tissues. In this editorial the two most important hypotheses on the etiology and pathogenesis of this group of conditions will be discussed. The "prion" hypothesis considers the possibility that a protein, derived from a normal component of the neuronal membranes may have a leading role, not only in the infectivity and transmissibility of these diseases, but in the pathological changes that ensue. A single host gene would code for both the normal and altered proteins. The altered protein would be partially insoluble and would result in the deposition of fibrils and rods which would precipitate in the form of amyloid. Since the involved protein would be coded for by the host, there would be no immune response against it.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676992     DOI: 10.1007/bf02337026

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  40 in total

1.  Infectious scrapie agent is apparently not as small as recent claims suggest.

Authors:  H Diringer; R H Kimberlin
Journal:  Biosci Rep       Date:  1983-06       Impact factor: 3.840

2.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change.

Authors:  C L Masters; E P Richardson
Journal:  Brain       Date:  1978-06       Impact factor: 13.501

5.  An electron microscopic study of natural scrapie sheep brain: further observations on virus-like particles and paramyxovirus-like tubules.

Authors:  H K Narang
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

6.  An electron-microscopic study of scrapie in the rat: further observations on "inclusion bodies" and virus-like particles.

Authors:  E J Field; H K Narang
Journal:  J Neurol Sci       Date:  1972-11       Impact factor: 3.181

7.  Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee.

Authors:  C J Gibbs; D C Gajdusek; D M Asher; M P Alpers; E Beck; P M Daniel; W B Matthews
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

8.  Experimental scrapie in mice: ultrastructural observations.

Authors:  J R Baringer; S B Prusiner
Journal:  Ann Neurol       Date:  1978-09       Impact factor: 10.422

9.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  Antibodies to the scrapie protein decorate prion rods.

Authors:  R A Barry; M P McKinley; P E Bendheim; G K Lewis; S J DeArmond; S B Prusiner
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.